Protocol No.: S2012

Randomized Phase II/III Trial of First Line Platinum/Etoposide with or without Atezolizumab (NSC#783608) in Patients with Advanced or Metastatic Poorly Differentiated Extrapulmonary Neuroendocrine Carcinomas (NEC)
Principal Investigator
Daboul, Nour
Phase
II/III
Age Group
Adult
Applicable Disease Sites
Gastrointestinal Cancers
Other Cancers
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Sabrina Rexroad, RN
Research Nurse
Phone: +1 304-293-6066

View on ClinicalTrials.gov